Landmark UK-led trial shows Avastin® (bevacizumab) can prolong life in women with advanced ovarian cancer

New data show that Avastin improves overall survival (OS) in women with high risk advanced ovarian cancer - the deadliest gynaecological cancer in the UK2 - offering hope for thousands of women diagnosed with the disease each year.3 Final data have been presented at the European Society of Gynaecological Oncology (ESGO) meeting in Liverpool from the international phase III ICON7 study, led by Leeds-based Dr Timothy Perren, which included 46 trial centres in the UK...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Ovarian Cancer Source Type: news